Anticardiolipin, anti-β2-glycoprotein I, antiprothrombin antibodies, and lupus anticoagulant in patients with systemic lupus erythematosus with a history of thrombosis

Journal of Rheumatology

Volumn 24, Issue 9, 1997, Pages 1710-1715

  Swadzba, Jakub ^b   De Clerck, Luc S ^a   Stevens, Wim J ^a   Bridts, Chris H ^a   Van Cotthem, Karin A ^a   Musial, Jacek ^b   Jankowski, Milosz ^b   Szczeklik, Andrzej ^b  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

2 glycoprotein I; Antiphospholipid syndrome; Cardiolipin; Lupus anticoagulant; Prothrombin; Systemic lupus erythematosus

Indexed keywords

BETA2 GLYCOPROTEIN 1; CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY; PROTHROMBIN;

ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOSIS;

ADULT; ANTIBODIES, ANTICARDIOLIPIN; BETA 2-GLYCOPROTEIN I; BIOLOGICAL MARKERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLYCOPROTEINS; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LUPUS COAGULATION INHIBITOR; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; PROTHROMBIN; SENSITIVITY AND SPECIFICITY; THROMBOSIS;

EID: 0030826383     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Hughes GRV: The antiphospholipid syndrome: Ten years on. Lancet 1993;342:1.
2. McNeil HP, Hunt JE, Krilis SA: Antiphospholipid antibodies: New insights into their specificity and clinical importance. Scand J Immunol 1992;36:647-52.
3. Khamashta MA, Hughes GRV: Antiphospholipid antibodies and antiphospholipid syndrome. Curr Opin Rheumatol 1995;7:389-94.
4. 2-glycoprotein 1 (apolipoprotein H). Proc Natl Acad Sci USA 1990;87:4120-4.
5. Galli M, Comfurius P, Maassen C, et al: Anticardiolipin antibodies directed not to cardiolipin but to plasma protein cofactor. Lancet 1990;335:1544-7.
6. Matsuura E, Igarashi Y, Fujimoto M, Ichikawa K, Koike T: Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease. Lancet 1990;336:177-8.
7. Roubey RAS: Autoantibodies to phospholipid binding plasma proteins: A new view of lupus anticoagulants and other antiphospholipid antibodies. Blood 1994;84:2854-67.
8. Triplett DA: Antiphospholipid-protein antibodies: Laboratory detection and clinical relevance. Thromb Res 1995;78:1-31.
9. Loeliger A: Prothrombin as cofactor of the circulating anticoagulant in systemic lupus erythematosus. Thromb Diath Haemorrh 1959;3:237-56.
10. Fleck RA, Rapaport SI, Rao LVM: Antiprothrombin antibodies and the lupus anticoagulant. Blood 1988;72:512-9.
11. Edson J, Vogt J, Hasegawa D: Abnormal prothrombin crossed immunoelectrophoresis in patients with lupus inhibitors. Blood 1984;64:807-16.
12. Oosting JD, Derksen RHWM, Bobbinck IWG, Hacgeng T, Bouma BN, de Groot P: Antiphospholipid antibodies directed against combination of phospholipids with prothrombin, protein C or protein S. An explanation for their pathogenic mechanism. Blood 1993;81:2618-25.
13. Harris EN, Gharavi AE, Patel SP, Hughes GRV: Evaluation of the anti-cardiolipin antibody test: Report of an international workshop held 4 April 1986. Clin Exp Immunol 1957;68:215-22.
14. Gigase PL, Bridts CH, De Clerck LS, Stevens WJ: A useful method for determining class-specific rheumatoid factors with computerized analyses of data. J Immunol Methods 1988;107:93-101.
15. Brandt JT, Triplett DA, Alving B, Scharer I: Criteria for the diagnosis of lupus anticoagulants: An update. Thromb Haemost 1995;74:1185-90.
16. 2glycoprotein I-dependent anticardiolipin antibodies in rheumatic diseases. Lupus 1995;4:27-31.
17. Ames PR, Pyke S, Iannoccone L, Brancaccio V: Antiphospholipid antibodies, haemostatic variables and thrombosis - a survey of 144 patients. Thromb Haemost 1995;73:768-73.
18. 2 glycoprotein I as an antigen. J Immunol Methods 1991;143:223-9.
19. 2GPI and role of other phospholipid cofactors. Thromb Haemost 1994;24:191-203.
20. 2 glycoprotein I antibodies with lupus type circulating anticoagulant and thrombosis in systemic lupus erythematosus. Am J Med 1992;93:181-6.
21. 2 glycoprotein I structure altered by interacting with an oxygen modified solid phase surface. J Exp Med 1994;179:457-62.
22. 2 glycoprotein I is bound to a suitable surface. Thromb Haemost 1995;73:29-34.
23. Wagenknecht DR, McIntyre JA: Changes in beta, glycoprotein I antigenicity induced by phospholipid binding. Thromb Haemost 1993;69:361-5.
24. Ghirardello A, Doria A, Ruffati A, et al: Antiphospholipid antibodies in systemic lupus erythematosus. Are they specific tools for the diagnosis of aPL syndrome? Ann Rheum Dis 1994;53:140-2.
25. 2 glycoprotein antibodies in autoimmune patients. Clin Exp Immunol 1994;95:310-5.
26. 2-glycoprotein-I than with antiphospholipid antibodies. J Rheumatol 1995;22:1899-906.
27. Pengo V, Biasiolo A, Brocco T, Tonetto S, Ruffatti A: Autoantibodies to phospholipid-binding plasma proteins in patients with thrombosis and phospholipid-reactive antibodies. Thromb Haemost 1996;75:721-4.
28. 2 glycoprotein I antibodies: Detection and association with thrombosis. Br J Haematol 1995;89:397-402.
29. Arvieux J, Darnige L, Caron C, Reber G, Bensa JC, Colom MG: Development of an ELISA for autoantibodies to prothrombin showing their prevalence in patients with lupus anticoagulants. Thromb Haemost 1995;74:1120-5.
30. Triplett DA, Brandt JT, Musgrave KA, Carol A, Orr MT: The relationship between lupus anticoagulants and antibodies to phospholipids. JAMA 1988;259:550-4.
31. Bevers EM, Galli M, Barbui T, Comfurius P, Zwaal RFA: Lupus anticoagulant IgGs (LA) are not directed to phospholipids only, but to a complex of lipid-bound human prothrombin. Thromb Haemost 1991;66:629-32.
32. Permpikul P, Rao LVM, Rapaport S: Functional and binding studies of the roles of prothrombin and beta 2 glycoprotein I in the expression of lupus anticoagulant. Blood 1994;83:2878-92.
33. Petri M, Rheinschmidt BA, Whiting-O'Keefe Q, Hellman D, Corash L: The frequency of lupus anticoagulant in systemic lupus erythematosus. Ann Intern Med 1987;106:524-31.
34. Triplett DA, Brandt JT, Musgrave KA, Orr CA: The relationship between lupus anticoagulants and antibodies to phospholipids. JAMA 1988;259:550-4.
35. Derksen RHWM, Hasselaar P, Blokzijl L, Gmelig Meyling FHJ, De Groot PG: Coagulation screen is more specific than the anticardiolipin antibody ELISA in defining a thrombotic subset of lupus patients. Ann Rheum Dis 1988;47:364-71.
36. Out HJ, van Vliet M, de Groot PG, Derksen RHWM: Prospective study of fluctuations of lupus anticoagulant activity and anticardiolipin antibody titre in patients with systemic lupus erythematosus. Ann Rheum Dis 1992;31:353-7.